HRP-Linked Monoclonal Antibody to Procollagen III N-Terminal Propeptide (PIIINP)

Citations

• Characterization of the specific and sustained GH1 expression induced by rAAV2/1 in normal adult male ratsPubMed: 20204528
• A Biomarker Panel for Non-alcoholic Steatohepatitis (NASH) and NASH-Related FibrosisPubMed: 20532833
• Comparison of Five Liver Fibrosis Indexes with Serum Levels of Laminin and N Terminal Peptide of Procollagen Type III in Chronic Hepatitis PatientsIntechopen: 18785
• Is there benefit in optimising heart failure treatment in over-80 year-old patients? (HF-80 study): study protocol for a randomized controlled trial.Trials: 1745-6215
• Aliskiren and Perindopril Reduce the Levels of Transforming Growth Factor-β in Patients With Non-Diabetic Kidney DiseaseNature: 201214
• Raised circulating tenascin-C in rheumatoid arthritis.PubMed: 23193984
• Serum markers of deranged myocardial collagen turnover: their relation to malignant ventricular arrhythmias in cardioverter-defibrillator recipients with heart failure.PubMed: 23067911
• Diagnostic potential of serum direct markers and non-invasive fibrosis models in patients with chronic hepatitis B.PubMed: 22734888
• Effects of coffee consumption in chronic hepatitis C: a randomized controlled trialPubmed: 23238034
• Procollagen III N-terminal propeptide and desmosine are released by matrix destruction in pulmonary tuberculosisPubmed: 23922364
• Prevalence, etiology and risk factors of pelvic organ prolapse in premenopausal primiparous womenSpringer: Source
• Protective Effects of Norursodeoxycholic Acid Versus Ursodeoxycholic Acid on Thioacetamide-induced Rat Liver FibrosisScienceDirect: S0973688314000073
• Retroperitoneale FibroseSpringer:Source
• The status of the pelvic floor in young primiparous womenWiley:Source
• Clinical significance of markers of collagen metabolism in rheumatic mitral valve diseasePubmed:24603967
• Serum and urinary procollagen III aminoterminal propeptide as a biomarker of obstructive nephropathy in childrenPubmed:24768785
• Fast food diet with CCl4 micro-dose induced hepatic-fibrosis-a novel animal modelPubmed:24884574
• DNMT3A silencing RASSF1A promotes cardiac fibrosis through upregulation of ERK1/2Pubmed:24945829
• Correlation of HBsAg titers with serum fibrotic maker in patients with chronic hepatitis B infection.Pubmed:24974647
• Relation of burden of myocardial fibrosis to malignant ventricular arrhythmias and outcomes in Fabry diseasePubmed:25073565
• B-cell depletion attenuates serological biomarkers of fibrosis and myofibroblast activation in IgG4-related diseasePubmed:25143523
• Biomarkers and Echocardiographic Predictors of Myocardial Dysfunction in Patients with HypertensionPubMed: 25747153
• The Multi-Biomarker Approach for Heart Failure in Patients with HypertensionPubMed: 25984599
• The Relationship of the Degree of Hepatic Fibrosis with Hyaluronic Acid, Type 4 Collagen, and Procollagen Type 3 N-Terminal Peptide Levels in Patients with Chronic Viral HepatitisOpenview: 8A0B8C97D72C61741371F33508760B75
• Pathological characterization and morphometric analysis of hepatic lesions in SHRSP5/Dmcr, an experimental non-alcoholic steatohepatitis model, induced by high-fat and high-cholesterol dietdoi:10.1111
• Prognostic value of collagen turnover biomarkers in cardiac resynchronization therapy: A subanalysis of the TRUST CRT randomized trial populationPubmed:26776557
• Procollagen markers in microdialysate can predict patient outcome after Achilles tendon rupturecontent:2
• Fibrosis of extracellular matrix is related to the duration of the disease but is unrelated to the dynamics of collagen metabolism in dilated cardiomyopathypubmed:27516211
• Left ventricular reverse remodeling is not related to biopsy-detected extracellular matrix fibrosis and serum markers of fibrosis in dilated cardiomyopathy, regardless of the definition used for LVRRpubmed:28004175
• Extracellular microRNA signature in chronic kidney disease.pubmed:28077372
• Renal Denervation Attenuates Multi-Organ Fibrosis and Improves Vascular Remodeling in Rats with Transverse Aortic Constriction Induced Cardiomyopathypubmed:27889753
• Procollagen C-Proteinase Enhancer 1 (PCPE-1) as a Plasma Marker of Muscleand Liver Fibrosis in Mice.pubmed:27458976
• 5-methoxytryptophan is a potential marker for post-myocardial infarction heart failure - apreliminary approach to clinical utility.pubmed:27526355
• Urinary Type III Procollagen Is Associated With Chronic Allograft Dysfunction and Predicts Graft Survival.pubmed:28219585
• Achilles tendon rupture healing is enhanced by intermittent pneumatic compression upregulating collagen type I synthesispubmed:28668970
• Association of HIV infection with biomarkers of kidney injury and fibrosis in the Multicenter AIDS Cohort Studypubmed:28054933
• Profilin‑1 contributes to cardiac injury induced by advanced glycation end‑products in ratspubmed:28901418
• Relationship of biomarkers of extracellular matrix with myocardial function in Type 2 diabetes mellituspubmed:28685602
• Left ventricular reverse remodeling is not related to biopsy‑detected extracellular matrix fibrosis and serum markers of fibrosis in dilated cardiomyopathy, regardless of the definition used for LVRR10.1007/s00380-016-0930-y
• Matrix Degradation in Human Immunodeficiency Virus Type 1–Associated Tuberculosis and Tuberculosis Immune Reconstitution Inflammatory Syndrome: A Prospective Observational Study10.1093/cid/cix231
• 12-month patterns of serum markers of collagen synthesis, transforming growth factor and connective tissue growth factor are similar in new-onset and chronic dilated cardiomyopathy in patients both with and without cardiac fibrosis.pubmed:28460256
• Prognostic value of fibrosis-related markers in dilated cardiomyopathy: A link between osteopontin and cardiovascular events.pubmed:29120858
• Urinary Biomarkers of Kidney Tubular Damage and Risk of Cardiovascular Disease and Mortality in EldersPubmed:29602632
• The Association of Biomarkers of Inflammation and Extracellular Matrix Degradation With the Risk of Abdominal Aortic Aneurysm: The ARIC Studyarticle:10.1007
• Circulating matrix metalloproteinases and procollagen propeptides in inguinal herniaPubmed:29484522
• Assessment of myocardial fibrosis by late gadolinium enhancement imaging and biomarkers of collagen metabolism in chronic rheumatic mitral regurgitation.Pubmed:29443354
• Association between reverse electrical remodeling and cardiac fibrosis markers in patients with cardiac resynchronization therapyPubmed:29512624
• N-терминальный пропептид проколлагена III типа в качестве возможного сывороточного маркера фиброза миокарда у больных сахарным диабетом 2 …:
• Improvement in Hepatic Fibrosis Biomarkers Associated with Chemokine Receptor Inactivation through Mutation or Therapeutic BlockadePubmed: 30239650
• microRNA-29a inhibits cardiac fibrosis in Sprague-Dawley rats by downregulating the expression of DNMT3A.Pubmed: 30297596
• Methods to improve the noninvasive diagnosis and assessment of disease severity in children with suspected nonalcoholic fatty liver disease (NAFLD): Study designDoi: 10.1016/j.cct.2018.10.012
• Association of serum levels of fibrosis-related biomarkers with disease activity in patients with IgG4-related diseasePubmed: 30547825
• Identification and Modulation of Microenvironment is Crucial for Effective MSC Therapy in Acute Lung InjuryPubmed: 30521764
• Direktor: Prof. Dr. med. Andreas Mügge
• Low fibrosis biomarker levels predict cardiac resynchronization therapy responsePubmed: 30988339
• Development and validation of an in vitro 3D model of NASH with severe fibrotic phenotypePubmed: 30972180
• Gum Acacia mitigates diclofenac nephrotoxicity by targeting monocyte chemoattractant protein-1, complement receptor-1 and pro-apoptotic pathwaysPubmed: 31042592
• Validation and Refinement of Noninvasive Methods to Assess Hepatic Fibrosis: Magnetic Resonance Elastography Versus Enhanced Liver Fibrosis IndexPubmed: 31468264
• Type 2 Diabetes Mellitus and Chronic Heart Failure with Midrange and Preserved Ejection Fraction: A Focus on Serum Biomarkers of FibrosisPubmed: 33224989
• Changes in hepatic fibrosis and vitamin D levels after viral hepatitis C eradication using direct-acting antiviral therapyPubmed: 33069226
• A randomized controlled trial of dapagliflozin on left ventricular hypertrophy in people with type two diabetes: the DAPA-LVH trialPubmed: 32578850
• Ассоциации толщины эпикардиального жира и циркулирующих маркеров фиброза миокарда у пациентов с инфарктом миокарда
• Association of Non©\Steroidal Anti©\Inflammatory Drugs with Kidney Health in Ambulatory Older Adults33305369
• Prognostic potential of cardiac structural and functional parameters and N-terminal propeptide of type III procollagen in predicting cardiac fibrosis one year after?¡­33431713
• Effect of vitamin D supplementation in patients with chronic hepatitis C after direct-acting antiviral treatment: a randomized, double-blind, placebo-controlled trial33614272
• Soluble CD163 Identifies Those at Risk for Increased Hepatic Inflammation & Fibrosis34104667
• A randomized controlled trial of dapagliflozin on left ventricular hypertrophy in people with type two diabetes32578850
• The Effect of Daily Methylsulfonylmethane (MSM) Consumption on High-Density Lipoprotein Cholesterol in Healthy Overweight and Obese Adults: A Randomized …34684621
• Association between Markers of Fibrosis and Heart Failure Incidence in Patients with Type 2 Diabetes Mellitus34778465
• Dual integrin αvβ3 and αvβ5 blockade attenuates cardiac dysfunction by reducing fibrosis in a rat model of doxorubicin-induced cardiomyopathy34296634
• Simple Predictors for Cardiac Fibrosis in Patients with Type 2 Diabetes Mellitus: The Role of Circulating Biomarkers and Pulse Wave VelocityPubmed:35628969
• Increase in Serum MMP-9 and TIMP-1 Concentrations during Alcohol Intoxication in Adolescents—A Preliminary StudyPubmed:35625637